Patient Information
Tramadol/Paracetamol Viatris 37.5 mg/325 mg
Coated Tablets EFG
Tramadol Hydrochloride/Paracetamol
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
1. What Tramadol/Paracetamol Viatris is and what it is used for
2. What you need to know beforestartingtotake Tramadol/Paracetamol Viatris
3. How to take Tramadol/Paracetamol Viatris
4. Possible side effects
5. Storage of Tramadol/Paracetamol Viatris
6. Contents of the pack and additional information
Tramadol/Paracetamol Viatris is a combination of two analgesics, tramadol hydrochloride and paracetamol, which act together to relieve pain.
Tramadol/Paracetamol Viatris is used for the treatment of moderate or severe pain. Your doctor will prescribe this medication if they consider a combination of tramadol hydrochloride and paracetamol to be appropriate.
Tramadol/Paracetamol Viatris should only be used by adults and adolescents 12 years of age or older.
Do not take Tramadol/Paracetamol Viatris:
Warnings and precautions
Consult your doctor or pharmacist before starting to take Tramadol/Paracetamol Viatris:
In all the cases described above, this medication should only be used with caution.
There is a weak risk that you may experience a serotonin syndrome that can occur after taking tramadol in combination with certain antidepressants or tramadol monotherapy. Consult your doctor immediately if you experience any of the symptoms associated with this severe syndrome (see section 4 "Possible side effects").
Tramadol should not be taken as a substitute for opioid-dependent patients, as it does not suppress withdrawal symptoms from morphine.
Tramadol can cause seizures even with the recommended doses. Therefore, patients with controlled epilepsy or those susceptible to seizures or convulsions should not be treated with Tramadol/Paracetamol Viatris unless absolutely necessary.
Tramadol is metabolized in the liver by an enzyme. Some people have a variant of this enzyme; this can affect people in different ways. In some people, they may not get sufficient pain relief, while others may be more likely to experience severe side effects. If you detect any of the following side effects, stop taking this medication and consult your doctor immediately: slow or shallow breathing, confusion, drowsiness, small pupils, feeling unwell, constipation, loss of appetite.
Extreme fatigue, loss of appetite, severe abdominal pain, nausea, vomiting, or low blood pressure. These may be indicators of adrenal insufficiency (low cortisol levels). If you experience these symptoms, contact your doctor, who will decide if you need to take hormone supplements.
Respiratory disturbances related to sleep
Tramadol/paracetamol may cause respiratory disturbances related to sleep, such as sleep apnea (pauses in breathing during sleep) and sleep-related hypoxemia (low oxygen levels in the blood). Symptoms may include pauses in breathing during sleep, nocturnal awakenings due to lack of breath, difficulty maintaining sleep, or excessive daytime somnolence. If you or someone else observes these symptoms, contact your doctor. Your doctor may consider reducing the dose.
Tolerance, dependence, and addiction
This medication contains tramadol, which is an opioid medication. Repeated use of opioids can make the medication less effective (you become accustomed to it, known as tolerance). Repeated use of Tramadol/paracetamol tablets can also lead to dependence, abuse, and addiction, which can result in a potentially fatal overdose. The risk of these side effects may increase with higher doses and longer use.
Dependence or addiction can make you feel like you no longer control the amount of medication you need to take or how often you need to take it.
The risk of becoming dependent or addicted to Tramadol/paracetamol varies from person to person. You may have a higher risk of becoming dependent or addicted to Tramadol/paracetamol if:
If you notice any of the following signs while taking Tramadol/paracetamol, it could be a sign that you have become dependent or addicted:
If you notice any of these signs, talk to your doctor to determine the best course of treatment for you, including when it is appropriate to stop taking it and how to do it safely (see section 3, If you stop taking Tramadol/paracetamol).
Children and adolescents
Tramadol/Paracetamol Viatris is not recommended for children under 12 years old. The safety and efficacy have not been established in children.
Tramadol is not recommended for children with respiratory problems, as the symptoms of tramadol toxicity may be worse for these children.
Abuse
At therapeutic doses, tramadol can cause withdrawal symptoms.
Surgery
The use of tramadol with anesthetics such as enflurane and nitrous oxide during general anesthesia may help the anesthesiologist recover the patient during operations if necessary. Until more information is available, it is recommended to avoid the use of tramadol during light anesthesia. Inform your doctor or dentist if you are to be anesthetized.
Use of Tramadol/Paracetamol Viatris with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.
Important: This medication contains paracetamol and tramadol. Inform your doctor if you are taking any other medication that contains paracetamol or tramadol so that you do not exceed the maximum daily dose.
The concomitant use of Tramadol/Paracetamol Viatris with sedatives, such as benzodiazepines or related drugs, increases the risk of somnolence, breathing difficulties (respiratory depression), coma, and may be potentially fatal. Therefore, concomitant use should only be considered when other treatment options are not possible.
However, if your doctor prescribes Tramadol/Paracetamol Viatris together with sedatives, your doctor should limit the dose and duration of concomitant treatment.
Inform your doctor of all sedatives you are taking, and follow your doctor's dose recommendation carefully. It may be helpful to inform your friends or family members to be aware of the symptoms and signs described above. Contact your doctor if you experience these symptoms.
Tramadol/Paracetamol Viatris should not be taken with::
Inform your doctor or pharmacist if you are taking:
The risk of side effects increases:
Tramadol/Paracetamol Viatris with alcohol
You should not drink alcohol during treatment, as alcohol with Tramadol/Paracetamol Viatris may make you feel drowsy.
Pregnancy and breastfeeding
As Tramadol/Paracetamol Viatris contains tramadol, do not take this medication during pregnancy.
Tramadol may pass into breast milk. Therefore, do not take Tramadol/Paracetamol Viatris more than once during breastfeeding or, if you take Tramadol/Paracetamol Viatris more than once, stop breastfeeding.
Based on human experience, it is not suggested that tramadol affects male or female fertility. There are no available data on the combination of tramadol and paracetamol in fertility.
If you are pregnant or breastfeeding, believe you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
This medication may cause drowsiness or dizziness, which may intensify with alcohol or other depressants that affect the central nervous system. If you feel drowsy or dizzy, do not drive or operate machinery.
Tramadol/Paracetamol Viatris contains sodium
This medication contains less than 1 mmol of sodium (23 mg) per tablet, which is essentially "sodium-free".
Always follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Before starting treatment and regularly during it, your doctor will explain what you can expect from the use of Tramadol/paracetamol, when and for how long you should take it, when you should contact your doctor and when you should interrupt it (see also section 2).
The recommended dose is:
Adults and adolescents (12 years or older):
Older adults (75 years or older):
In older adults (75 years or older), the excretion of tramadol hydrochloride may be delayed. If this applies to you, your doctor may recommend prolonging the dosing interval.
Severe liver and/or kidney disease (insufficiency) and/or patients on dialysis:
Patients with severe liver and/or kidney insufficiency should not take Tramadol/Paracetamol Viatris. If your insufficiency is mild or moderate, your doctor may recommend prolonging the dosing interval.
Use in children under 12 years
Tramadol/Paracetamol Viatris is not recommended for use in children under 12 years.
Administration form
Treatment duration
Do not take this medication for longer than strictly necessary.
If repeated or prolonged treatment with this medication is required (due to the nature or severity of the disease), caution should be exercised and regular checks should be made to evaluate whether continued treatment is necessary. If possible, pauses in treatment should be introduced during long-term treatment.
If you believe the effect of Tramadol/Paracetamol Viatris is too strong (e.g., you feel very drowsy or have difficulty breathing) or too weak (e.g., inadequate pain relief), contact your doctor.
If you take more Tramadol/Paracetamol Viatris than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone 91 562 04 20, indicating the medication and the amount administered.
If you forget to take Tramadol/Paracetamol Viatris
If you forget to take this medication, you can skip the missed dose and continue with the treatment as normal, or you can take the missed tablet, but you will have to wait 6 hours for the next dose.
Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Tramadol/Paracetamol Viatris
You should not stop taking this medication abruptly, unless your doctor tells you to. If you want to stop taking the medication, you should talk to your doctor first, especially if you have been taking it for a long time. Your doctor will inform you about the time and way to stop taking it, which may involve gradually reducing the dose to reduce the risk of unnecessary adverse effects (withdrawal symptoms).
Generally, there will be no adverse effects when treatment with Tramadol/Paracetamol Viatris is interrupted. However, in rare cases, people who have been taking tramadol for a while may feel unwell if they stop treatment abruptly.
If therapy is no longer necessary, you should interrupt treatment by gradually reducing the dose to avoid withdrawal symptoms.
People may:
Very few people may also experience:
If you experience any of these symptoms after interrupting treatment with Tramadol/Paracetamol Viatris, consult your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you think you may be experiencing any of the following side effects, stop taking this medicine and contact your doctor or go immediately to the nearest hospital. You may need medical attention if you experience these side effects:
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data)
Other side effects include:
Very common(may affect more than 1 in 10 people)
Common(may affect up to 1 in 10 people)
Rare(may affect up to 1 in 1,000 people)
Very rare(may affect up to 1 in 10,000 people)
Frequency not known(cannot be estimated from available data)
Other side effects reported by people using medications containing only tramadol or only paracetamol:
Rare (may affect up to 1 in 1,000 people)
Frequency not known(cannot be estimated from available data)
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keepthis medicationout of the sight and reach of children.
Store this medication in a safe and protected place, where other people cannot access it. It can cause serious harm and be fatal to individuals when not prescribed.
Do not use this medication after the expiration date that appears on the blister pack and on the box after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Deposit the containers and medications you no longer need at the SIGRE collection pointat the pharmacy. Ask your pharmacist how to dispose of the containers and medications you no longer need. This will help protect the environment.
Composition of Tramadol/Paracetamol Viatris
Core of the film-coated tablet:
pregelatinized cornstarch, cornstarch, sodium carboxymethylstarch of potato (potato starch), microcrystalline cellulose, magnesium stearate.
Film coating::
hypromellose (E-464), titanium dioxide (E-171), triacetin, yellow iron oxide (E-172).
Appearance of the product and contents of the package
Your medicine is presented as a film-coated tablet, light yellow and elongated.
The PVC/PVdC/Al or PVC/Al blisters contain 2, 10, 20, 30, 40, 50, 60, 70, 80, 90, and 100 film-coated tablets.
Only some package sizes may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible for manufacturing
MEDIS INTERNATIONAL a.s.
Výrobní závod Bolatice
Prúmyslová 961/16
747 23 Bolatice
Republic of Czech
O
McDermott Laboratories Ltd. T/A Gerard Laboratories T/A Mylan Dublin
35/36 Baldoyle Industrial Estate
Grange Road, Dublin 13
Ireland
O
Martin Dow
Goualle Le Puy, Champ de Lachaud
19250 Meymac
France
O
Mylan Hungary Kft.
Mylan utca 1.
Komarom, 2900
Hungary
You can request more information about this medicine by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medicine has been authorized in the EEA member states with the following names:
SlovakiaTramylpa 37.5 mg/325 mg
SpainTramadol/Paracetamol Viatris 37.5 mg/325 mg film-coated tablets EFG
PortugalTramadol + Paracetamol Mylan 37.5 mg + 325 mg film-coated tablets
Republic of CzechTramylpa 37.5 mg/325 mg coated tablets
Last review date of this leaflet:May2024
Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) https://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.